quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:02·567d
SECFiling
Augmedix Inc. logo

SEC Form EFFECT filed by Augmedix Inc.

AUGX· Augmedix Inc.
Consumer Discretionary
Original source

Companies

  • AUGX
    Augmedix Inc.
    Consumer Discretionary

Recent analyst ratings

  • Jul 22UpdateLake Street-
  • Jul 22UpdateB. Riley Securities$2.35
  • May 14UpdateMaxim Group$5.00
  • May 14UpdateEvercore ISI$1.50
  • Apr 3UpdateB. Riley Securities$5.50
  • Dec 15UpdateEvercore ISI$6.00

Related

  • SEC556d
    SEC Form 15-12G filed by Augmedix Inc.
  • INSIDER566d
    Director Redmile Group, Llc returned $75,402,504 worth of shares to the company (32,086,172 units at $2.35) (SEC Form 4)
  • INSIDER566d
    SEC Form 4 filed by Director Faulkner Robert C.
  • 13D/G566d
    Amendment: SEC Form SC 13D/A filed by Augmedix Inc.
  • INSIDER566d
    Director Febbo William J returned $382,070 worth of shares to the company (162,583 units at $2.35), closing all direct ownership in the company (SEC Form 4)
  • INSIDER566d
    SEC Form 4 filed by SVP, ENGINEERING Levy Tomer
  • INSIDER566d
    CHIEF TECHNOLOGY OFFICER Chatterjee Saurav returned $13,733 worth of shares to the company (5,844 units at $2.35), closing all direct ownership in the company (SEC Form 4)
  • INSIDER567d
    CHIEF OPERATING OFFICER Breber Sandra returned $47,693 worth of shares to the company (20,295 units at $2.35), closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022